作为乙型肝炎病毒检测和治疗工具箱的CRISPR/Cas的应用
Anuj Kumar1,2, Emmanuel Combe1,2, Léa Mougené1,2
1Cancer Research Center of Lyon, INSERM U1052, CNRS UMR 5286, 69008 Lyon, France.
Viruses
|October 26, 2024
概括
通过向病毒DNA和RNA,CRISPR/Cas技术为抗击乙型肝炎病毒 (HBV) 感染提供了新的方法. 本综述探讨了这些进展,包括非DSB方法,用于HBV抑制和诊断.
科学领域:
- 病毒学 病毒学
- 分子生物学分子生物学
- 基因编辑技术的技术
背景情况:
- 乙型肝炎病毒 (HBV) 感染是全球主要的健康问题,导致慢性肝炎,肝硬化和肝癌.
- 病毒的持久性是由共封闭的圆形DNA (cccDNA) 和集成的HBVDNA维持的.
- 目前的治疗方法在消除病毒方面存在局限性.
研究的目的:
- 提供关于CRISPR/Cas技术应用在抑制HBV的全面概述.
- 要突出最近的进展,特别是非双链 (非DSB) 断裂方法.
- 讨论CRISPR/Cas在HBV诊断和ccDNA研究中的更广泛的实用性.
主要方法:
- 对针对HBV的CRISPR/Cas系统现有文献的综述.
- 分析涉及直接向ccccDNA和集成HBVDNA的策略.
- 探索间接抑制方法,包括RNA降解和宿主蛋白向.
主要成果:
- 通过向病毒遗传物质,CRISPR/Cas系统在抑制HBV方面表现有前途.
- 非DSB的CRISPR/Cas方法为更安全,更有效的病毒抑制提供了潜力.
- CRISPR/Cas技术对于HBV诊断和了解ccDNA生物学也是有价值的.
结论:
- 克里斯普尔/卡斯技术为抗击HBV感染提供了多功能和强大的工具包.
- 新的非DSB CRISPR/Cas策略正在成为关键的治疗途径.
- 克里斯普尔/卡斯的多种应用范围不仅仅是直接抑制,还包括HBV的诊断和基础研究.
更多相关视频
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
2.2K
11:14Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
Published on: November 7, 2018
18.3K
相关概念视频
CRISPR
49.7K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
49.7K
CRISPR and crRNAs
16.8K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.8K
